CIM | Chimera InvestmentNYSEReal EstateCommon stock golden cross and death cross projections, cross tests and history

$8.29
-$0.15 (-1.78%)

Chimera Investment (CIM) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat below the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $8.29 vs 50 $9.89 / 200 $12.25
Projection
No cross projected
Test
No active test
Last cross
Death cross 10 Aug 2026 ยท projected 25 bars out

Weekly as of 30 Oct 16:00 ET

Price
below both $8.30 vs 50 $12.38 / 200 $14.28
Projection
No cross projected
Test
No active test
Last cross
No cross on record

4-hour as of 3 Nov 16:00 ET

Price
below both $8.29 vs 50 $8.67 / 200 $11.29
Projection
No cross projected
Test
No active test
Last cross
Death cross 7 Jul 2026 ยท projected 4 bars out

Cross history

29
crosses on record since 2017
14 golden15 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
10 Aug 2026Death moderatedaily25 bars outNot tested
7 Jul 2026Death4-hour4 bars outNot tested
21 Apr 2026Golden moderatedaily11 bars out4 bar cross test
12 Feb 2026Golden4-hour4 bars outNot tested
6 Nov 2025Death moderatedaily28 bars outNot tested

About CIM

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$11.7M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorReal Estate
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.